FDA NDC Directory · JSON-LD · Markdown

POSACONAZOLE

NDC 31722-370 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219057
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsPOSACONAZOLE (18 mg/mL)
Marketing started20241223
Package count1

External sources

Source: openFDA. Public-domain (CC0).